An abnormal p53 and beta-catenin expression may be identified in a subset of ACC patients which are typically enriched in high-grade carcinomas that are reflected in poor-prognostic molecular clusters [32, 33]. This evidence concerns the gene CTNNB1 and adrenal cortex carcinoma.